AMYLOIDOSIS

Clinical trials for AMYLOIDOSIS explained in plain language.

Never miss a new study

Get alerted when new AMYLOIDOSIS trials appear

Sign up with your email to follow new studies for AMYLOIDOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 21 Not yet recruiting 2 Not yet finished but already full! 3 Completed 6 Terminated 1

New drug aims to stop rare protein from destroying hearts

Disease control Terminated

This study tested a drug called inotersen in 31 adults with a rare condition where a faulty protein builds up in the heart, causing damage. The drug is designed to lower the amount of that protein made by the liver. Researchers used heart imaging to see if the drug could slow or …

Matched conditions: AMYLOIDOSIS

Phase: PHASE2 • Sponsor: Brigham and Women's Hospital • Aim: Disease control

Last updated Jun 15, 2026 19:03 UTC

AMYLOIDOSIS

Get alerted when new AMYLOIDOSIS trials appear

New drug aims to stop rare protein from destroying hearts